Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cells

Blood

Volumn 115, Issue 23, 2010, Pages 4914-4922

  Coghill, James M ^a   Carlson, Michael J ^a   Panoskaltsis Mortari, Angela ^b   West, Michelle L ^a   Burgents, Joseph E ^a   Blazar, Bruce R ^b   Serody, Jonathan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; ENHANCED GREEN FLUORESCENT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CCR7 PROTEIN, MOUSE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL TRANSPLANTATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DONOR; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MASTOCYTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE; WILD TYPE; ANIMAL; CELL PROLIFERATION; GENETICS; HUMAN; IMMUNOLOGY; MOUSE MUTANT; TRANSPLANTATION;

ANIMALS; CELL PROLIFERATION; CYTOKINES; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HUMANS; INFLAMMATION MEDIATORS; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, CCR7; SPLEEN; T-LYMPHOCYTES;

EID: 77954734137     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-08-239848     Document Type: Article

References (26)

1. Beilhack A, Schulz S, Baker J, et al. In vivo analysis of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106(3):1113-1122. (Pubitemid 41076462)
2. Panoskaltsis-Mortari A, Price A, Hermanson JR, et al. In vivo imaging of graft-versus-host-disease in mice. Blood. 2004;103(9):3590-3598.
3. Wysocki CA, Panoskaltis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood. 2005;105(11):4191-4199.
4. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4(2):154-160. (Pubitemid 36193017)
5. Zhou S, Ueta H, Xu X, et al. Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GVHD: a role of gut lymph nodes. Int Immunol. 2007;20(3):385-394.
6. Beilhack A, Schulz S, Baker J, et al. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood. 2008;111(5):2919-2928.
7. Anderson BE, Taylor PA, McNiff JM, et al. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Blood. 2008;111(10):5242-5251.
8. Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999;99(1):23-33. (Pubitemid 29468627)
9. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, Exodus-2) triggers lymphocyte function-associated 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med. 2000;191(1):61-76.
10. Tangemann K, Gunn MD, Giblin P, et al. A high endothelial cell-derived chemokine induces rapid, efficient, and subset-selective arrest of rolling T lymphocytes on a reconstituted endothelial substrate. J Immunol. 1998;161(11):6330-6337. (Pubitemid 28536009)
11. Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol. 2004;173(2):845-854.
12. Carlson MJ, West ML, Coghill JM, et al. In vitro differentiated Th17 cells mediate lethal acute GVHD with severe cutaneous and pulmonary manifestations. Blood. 2009;113(6):1365-74.
13. Taylor PA, Panoskaltsis-Mortari A, Swedin JM, et al. L-selectin(hi) but not the L-selectin(lo) CD4+CD25+ T regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood. 2004;104(12):3804-3812.
14. Ralph P, Moore MA, Nilsson K. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med. 1976;143(6):1528-33.
15. Kusser KL, Randall TD. Simultaneous detection of eGFP and cell surface markers by fluorescence microscopy in lymphoid tissues. J Histochem Cytochem. 2003;51(1):5-14.
16. Staton TL, Habtezion A, Winslow MM, et al. CD8+ recent thymic emigrants home to and efficiently repopulate the small intestine epithelium. Nat Immunol. 2006;7(5):482-488.
17. Serody JS, Burkett SE, Panoskaltsis-Mortari A, et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood. 2000;96(9):2973-2980.
18. Nikolic B, Lee S, Bronson RT, et al. Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest. 2000;105(9):1289-1298. (Pubitemid 30266082)
19. 7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease. Blood. 2005;106(12):4009-4015.
20. van Den Brink MR, Moore E, Horndasch KJ, et al. Fas-deficient lpr mice are more susceptible to graft-versus-host disease. J Immunol. 2000;164(1):469-480. (Pubitemid 30013023)
21. Ziegler E, Oberbarnscheidt M, Bulfone-Paul S, et al. CCR7 signaling inhibits T cell proliferation. J Immunol. 2007;179(10):6485-6493.
22. Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281(1-2):65-78.
23. Nguyen VH, Zeiser R, daSilva DL, et al. In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood. 2007;109(6):2649-2656.
24. Edinger M, Hoffman P, Ermann J, et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med. 2003;9(9):1144-1150. (Pubitemid 37173698)
25. Schneider MA, Meingassner JG, Lipp M, et al. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med. 2007;204(4):735-745.
26. Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute GVHD. Blood. 2005;106(9):3300-07.